Alumis ALMS
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$10.94M (3 inflow days, 17 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 40.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 4.52% to 8.52% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Morgan Stanley | Public Company | 2026/Q3 | +1,843,427 | 1.7% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +1,843,427 | 1.7% |
| Citigroup Inc. | Public Company | 2026/Q3 | +835,251 | 0.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +761,043 | 2.3% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +636,875 | 0.5% |
| Kera Capital Partners, Inc. | Family Office/Trust | 2026/Q3 | +403,818 | 0.3% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +376,825 | 0.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +360,253 | 6.6% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +322,091 | 0.3% |
| Barclays PLC | Public Company | 2026/Q3 | +278,586 | 0.3% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +230,265 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +158,746 | 0.2% |
| Samsara BioCapital LLC | VC/PE Fund | 2026/Q3 | +890,590 | 5.6% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +158,746 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +5,795,331 | 5.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 1 Nov 2026 | Roy Hardiman | Chief Business & Strategy Officer | Open Market Disposition | -652 | $6.52 | 194,261 |
| 1 Nov 2026 | John Schroer | Chief Financial Officer | Open Market Disposition | -794 | $6.52 | 4,674 |
| 1 Nov 2026 | David Goldstein | Chief Scientific Officer | Open Market Disposition | -629 | $6.52 | 229,009 |
| 1 Nov 2026 | Jorn Drappa | Chief Medical Officer & Head of Research and Development | Open Market Disposition | -593 | $6.52 | 38,802 |
| 1 Nov 2026 | Sanam Pangali | Chief Legal Officer | Open Market Disposition | -332 | $6.52 | 2,540 |
| 1 Nov 2026 | Mark Bradley | Chief Development Officer | Open Market Disposition | -623 | $6.52 | 69,571 |
| 7 Sep 2026 | Samsara BioCapital LLC | Open Market Disposition | -96,131 | $10.55 | 7,235,809 | |
| 7 Sep 2026 | Samsara BioCapital LLC | Open Market Acquisition | +986,721 | $11.17 | 7,235,809 | |
| 2 Aug 2026 | Roy Hardiman | Chief Business & Strategy Officer | Open Market Disposition | -2,692 | $26.37 | 195,496 |
| 2 Aug 2026 | John Schroer | Chief Financial Officer | Open Market Disposition | -3,282 | $26.37 | 3,718 |
| 2 Aug 2026 | David Goldstein | Chief Scientific Officer | Open Market Disposition | -2,596 | $26.37 | 230,201 |
| 2 Aug 2026 | Jorn Drappa | Chief Medical Officer & Head of Research and Development | Open Market Disposition | -2,447 | $26.37 | 39,925 |
| 2 Aug 2026 | Sanam Pangali | Chief Legal Officer | Open Market Disposition | -1,364 | $26.37 | 3,080 |
| 2 Aug 2026 | Mark Bradley | Chief Development Officer | Open Market Disposition | -2,572 | $26.37 | 70,752 |
| 5 Jul 2026 | Sanam Pangali | Chief Legal Officer | Derivative Exercise and Sale | -5,000 | $28.00 | 1,111 |
| 29 Jun 2026 | Srinivas Akkaraju | Independent Director | Other Acquisition | +3,553 | – | 3,553 |
| 29 Jun 2026 | Srinivas Akkaraju | Independent Director | Other Derivative Acquisition | +15,528 | $28.14 | 15,528 |
| 29 Jun 2026 | Sapna Srivastava | Lead Independent Director | Other Acquisition | +3,553 | – | 3,553 |
| 29 Jun 2026 | Sapna Srivastava | Lead Independent Director | Other Derivative Acquisition | +15,528 | $28.14 | 15,528 |
| 29 Jun 2026 | Lynn Tetrault | Independent Director | Other Acquisition | +3,553 | – | 3,553 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 11,032,098 | 8.5% | 5.8 |
| 15 Oct 2026 | 11,079,936 | 8.6% | 4.9 |
| 30 Sep 2026 | 10,295,705 | 8.0% | 3.6 |
| 15 Sep 2026 | 6,299,106 | 4.9% | 1.0 |
| 31 Aug 2026 | 5,645,753 | 4.4% | 7.1 |
| 14 Aug 2026 | 5,853,901 | 4.5% | 6.5 |
No comments yet — be the first to weigh in on ALMS.
Sign in to join the discussion.